Page 85 - 《中国药房》2024年2期
P. 85

[12]
          KIM-1 和 Cys-C 是检测肾损伤的生物标志物 。本研                          1864.
          究结果显示,ECH 干预后,URE 大鼠血清中 BUN、Scr、                   [ 6 ]  LI X S,ZHENG J,WANG J,et al. Effects of uremic clea-
          β2-MG、24 h UP、NGAL、KIM-1 和 Cys-C 水平均显著降                 rance granules on p38 MAPK/NF-κB signaling pathway,
          低,且呈剂量依赖性。这表明ECH能抑制肾损伤标志物                               microbial  and  metabolic  profiles  in  end-stage  renal  disease
          分泌,增强肾功能,改善URE大鼠肾损伤。                                    rats receiving peritoneal dialysis[J]. Drug Des Devel Ther,
              有研究表明,URE 患者治疗后 NF-κB 水平下降,炎                        2022,16:2529-2544.
                   [13]
          症状态减轻 。URE可通过NF-κB信号通路过度激活来                        [ 7 ]  王晔,高宏宇,张莉,等. JNK/NF-κB通路在沙利度胺减
                                                                  轻膜性肾病大鼠足细胞损伤中的作用[J]. 中国中西医结
          诱发心肌损伤,而抑制该信号通路过度激活,能缓解炎                                合肾病杂志,2022,23(10):910-912,946.
                                             [14]
          症反应,保护心肌细胞,预防 URE 心肌病 。本研究结                             WANG Y,GAO H Y,ZHANG L,et al. The role of JNK/
          果显示,ECH 干预后,URE 大鼠肾组织中 p38 MAPK 和                       NF-κB pathway in thalidomide alleviating podocyte
          NF-κB p65的磷酸化水平均显著下调,且呈剂量依赖性。                           injury  in  rats  with  membranous  nephropathy[J].  Chin  J
          而在 ECH 处理的基础上给予 p38 MAPK 激活剂茴香霉                         Integr Tradit West Nephrol,2022,23(10):910-912,946.
          素后,与高剂量 ECH 组相比,URE 大鼠肾组织中 p38                     [ 8 ]  SUN  Z  H,ZHENG  W  L,TENG  J,et  al.  Resveratrol
          MAPK和NF-κB p65的磷酸化水平均显著升高,血清中                           reduces kidney injury in a rat model of uremia and is asso-
          TNF-α、IL-1β、IL-6、BUN、Scr、β2-MG、24 h UP、NGAL、            ciated with increased expression of heat shock protein 70
          KIM-1、Cys-C和肾组织中MDA水平、α-SMA阳性表达率                       (Hsp70)[J]. Med Sci Monit,2020,26:e919086.
          均显著升高,肾组织中SOD活性和E-cadherin阳性表达                     [ 9 ]  RAFIEE  Z,MOAIEDI  M  Z,GORJI A  V,et  al.  P-cou-
          率均显著降低,可见茴香霉素逆转了高剂量ECH对URE                              maric  acid  mitigates  doxorubicin-induced  nephrotoxicity
                                                                  through suppression of oxidative stress,inflammation and
          大鼠肾损伤的改善作用。这表明ECH能抑制p38 MAPK/
                                                                  apoptosis[J]. Arch Med Res,2020,51(1):32-40.
          NF-κB信号通路的表达和激活,抑制肾脏炎症反应和氧化
                                                             [10]  ZHU  J  F,ZHANG  Y  F,SHI  L,et  al.  RP105  protects
          应激反应,保护肾功能,减轻URE大鼠肾损伤程度。
                                                                  against  ischemic  and  septic  acute  kidney  injury  via  sup‐
              综上所述,ECH可能通过抑制p38 MAPK/NF-κB信
                                                                  pressing TLR4/NF-κB signaling pathways[J]. Int Immuno‐
          号通路的激活来抑制 URE 大鼠的炎症反应和氧化应激                              pharmacol,2022,109:108904.
          反应,增强肾功能,改善肾损伤。但其在临床上改善                            [11]  ZHANG L,SUN J,ZHANG M,et al. The significance of
          URE症状的具体作用效果还需要进一步研究。                                   combined detection of CysC,urinary mAlb and β2-MG in
          参考文献                                                    diagnosis  of  the  early  renal  injury  in  pregnancy-induced
          [ 1 ]  DING Y H,ZHANG Y,WANG Z H,et al. Echinacoside    hypertension syndrome[J]. Saudi J Biol Sci,2019,26(8):
              from  Cistanche  tubulosa  ameliorates  alcohol-induced   1982-1985.
              liver  injury  and  oxidative  stress  by  targeting  Nrf2[J].   [12]  ŞEN  S,ÖZALP  KıZıLAY  D,TANELI  F,et  al.  Urinary
              FASEB J,2023,37(3):e22792.                          NGAL  is  a  potential  biomarker  for  early  renal  injury  in
          [ 2 ]  ZHAO  Y  D,YI  Y,GU  B,et  al.  Echinacoside  protects   insulin resistant obese non-diabetic children[J]. J Clin Res
              adenine-induced uremic rats from sciatic nerve damage by   Pediatr Endocrinol,2021,13(4):400-407.
              up-regulating α-klotho[J]. J Musculoskelet Neuronal Inter-  [13]  罗煜,吴嘉思,朱正文,等 . 盐酸巴马汀抑制 NF-κB/p38
              act,2021,21(3):413-421.                             MAPK 信号通路及 NLRP3 炎症小体抗炎机制研究[J].
          [ 3 ]  米妍妍,徐曼,王春双 . 松果菊苷通过 IL-33/STAT 轴对                中药新药与临床药理,2020,31(7):762-768.
              脓毒症大鼠急性肾损伤的保护作用及机制研究[J]. 西部                         LUO  Y,WU  J  S,ZHU  Z  W,et  al.  Anti-inflammatory
              医学,2023,35(4):519-523,528.                          effect  of  palmatine  hydrochloride  and  its  mechanism  in
              MI Y Y,XU  M,WANG  C  S.  Effect  and  mechanism  of   regulation  of  NF- κB/p38  MAPK  signaling  pathway  and
              echinacoside on acute kidney injury in septic rats through   NLRP3  inflammasome[J].  Tradit  Chin  Drug  Res  Clin
              IL-33/STAT axis[J]. Med J West China,2023,35(4):519-  Pharmacol,2020,31(7):762-768.
              523,528.                                       [14]  董倩兰,张琳萍,闫晓辉,等. 肾衰宁胶囊对尿毒症贫血
          [ 4 ]  高书涛 . 松果菊苷抑制 NF-κB/NLRP3 信号通路减轻脊                 患者外周血Hb、TNF-α及NF-κB水平的影响[J]. 中国中
              髓损伤的实验研究[D]. 乌鲁木齐:新疆医科大学,2020.                      西医结合肾病杂志,2020,21(3):241-242.
              GAO  S  T.  Alleviative  effects  of  echinacoside  against       DONG  Q  L,ZHANG  L  P,YAN  X  H,et  al.  Effect  of
              spinal  cord  injury  via  inhibiting  NF- κB/NLRP3  signaling   Shenshuaining  capsule  on  the  levels  of  Hb,TNF- α  and
              pathway[D]. Urumqi:Xinjiang Medical University,2020.  NF-κB in peripheral blood of patients with uremic anemia
          [ 5 ]  ZHANG H F,WANG Y L,GAO C,et al. Salvianolic acid   [J].  Chin  J  Integr  Tradit  West  Nephrol,2020,21(3):
              A attenuates kidney injury and inflammation by inhibiting   241-242.
              NF-κB and p38 MAPK signaling pathways in 5/6 nephrec‐         (收稿日期:2023-07-21  修回日期:2023-12-29)
              tomized rats[J]. Acta Pharmacol Sin,2018,39(12):1855-                               (编辑:邹丽娟)



          中国药房  2024年第35卷第2期                                                 China Pharmacy  2024 Vol. 35  No. 2    · 203 ·
   80   81   82   83   84   85   86   87   88   89   90